Dan Lv1, Zepu Wang2, Shuai Ji1, Xiaoxi Wang1, Huiqing Hou1. 1. Physical Examination Center, Hebei General Hospital, Shijiazhuang City, Hebei Province, People's Republic of China. 2. Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang City, Hebei Province, People's Republic of China.
Abstract
OBJECT: Studies have shown a link between homocysteine (Hcy) and heart diseases, kidney diseases, cerebrovascular diseases, liver diseases, and other pathological conditions. However, the relationship between Hcy and liver fibrosis (LF) is unclear. Here, we studied the link between plasma Hcy concentration and LF. METHODS: We determined and recorded the plasma Hcy concentration, general biochemical parameters, and liver stiffness measurement (LSM) in 1582 subjects, followed by statistical data analyses. RESULTS: During different stages of LF, we found a considerable difference (p <0.001 unless specified) in body mass index (BMI), sex, age, Hcy, the levels of alanine transaminase (ALT), gamma-glutamyl transpeptidase (GGT; P = 0.012), triglycerides (TG; P = 0.006), low-density lipoprotein cholesterol (LDL-C), fasting blood glucose (FBS), and platelet count (PLT). There was a strong association between the plasma Hcy concentration and the serum biomarkers of LF (P <0.001) and the values of LSM (P <0.001). CONCLUSION: The plasma Hcy concentration was substantially different among different stages of LF. The higher the plasma Hcy concentration, the more evident was the degree of LF.
OBJECT: Studies have shown a link between homocysteine (Hcy) and heart diseases, kidney diseases, cerebrovascular diseases, liver diseases, and other pathological conditions. However, the relationship between Hcy and liver fibrosis (LF) is unclear. Here, we studied the link between plasma Hcy concentration and LF. METHODS: We determined and recorded the plasma Hcy concentration, general biochemical parameters, and liver stiffness measurement (LSM) in 1582 subjects, followed by statistical data analyses. RESULTS: During different stages of LF, we found a considerable difference (p <0.001 unless specified) in body mass index (BMI), sex, age, Hcy, the levels of alanine transaminase (ALT), gamma-glutamyl transpeptidase (GGT; P = 0.012), triglycerides (TG; P = 0.006), low-density lipoprotein cholesterol (LDL-C), fasting blood glucose (FBS), and platelet count (PLT). There was a strong association between the plasma Hcy concentration and the serum biomarkers of LF (P <0.001) and the values of LSM (P <0.001). CONCLUSION: The plasma Hcy concentration was substantially different among different stages of LF. The higher the plasma Hcy concentration, the more evident was the degree of LF.
Authors: Magdy Amin El Serafy; Abdel Meguid Kassem; Heba Omar; Mohammad Shaaban Mahfouz; Maissa El Said El Raziky Journal: Arab J Gastroenterol Date: 2017-06-01 Impact factor: 2.076
Authors: Claudia Verveer; Pieter E Zondervan; Fibo J W ten Kate; Bettina E Hansen; Harry L A Janssen; Robert J de Knegt Journal: Liver Int Date: 2011-10-17 Impact factor: 5.828
Authors: Peter J Eddowes; Magali Sasso; Michael Allison; Emmanouil Tsochatzis; Quentin M Anstee; David Sheridan; Indra N Guha; Jeremy F Cobbold; Jonathan J Deeks; Valérie Paradis; Pierre Bedossa; Philip N Newsome Journal: Gastroenterology Date: 2019-01-25 Impact factor: 22.682